Department of Geriatrics, UZ Leuven, Leuven, Belgium.
Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Nutr Rev. 2021 Jan 9;79(2):121-147. doi: 10.1093/nutrit/nuaa011.
Sarcopenia is a progressive and generalized skeletal muscle disorder associated with an increased risk of adverse outcomes such as falls, disability, and death. The Belgian Society of Gerontology and Geriatrics has developed evidence-based guidelines for the prevention and treatment of sarcopenia. This umbrella review presents the results of the Working Group on Nutritional Interventions.
The aim of this umbrella review was to provide an evidence-based overview of nutritional interventions targeting sarcopenia or at least 1 of the 3 sarcopenia criteria (ie, muscle mass, muscle strength, or physical performance) in persons aged ≥ 65 years.
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, the PubMed and Web of Science databases were searched for systematic reviews and meta-analyses reporting the effect of nutritional supplementation on sarcopenia or muscle mass, strength, or physical performance.
Two authors extracted data on the key characteristics of the reviews, including participants, treatment, and outcomes. Methodological quality of the reviews was assessed using the product A Measurement Tool to Assess Systematic Reviews. Three authors synthesized the extracted data and generated recommendations on the basis of an overall synthesis of the effects of each intervention. Quality of evidence was rated with the Grading of Recommendations Assessment, Development and Evaluation approach.
A total of 15 systematic reviews were included. The following supplements were examined: proteins, essential amino acids, leucine, β-hydroxy-β-methylbutyrate, creatine, and multinutrient supplementation (with or without physical exercise). Because of both the low amount and the low to moderate quality of the reviews, the level of evidence supporting most recommendations was low to moderate.
Best evidence is available to recommend leucine, because it has a significant effect on muscle mass in elderly people with sarcopenia. Protein supplementation on top of resistance training is recommended to increase muscle mass and strength, in particular for obese persons and for ≥ 24 weeks. Effects on sarcopenia as a construct were not reported in the included reviews.
肌肉减少症是一种进行性和全身性的骨骼肌疾病,与不良后果(如跌倒、残疾和死亡)的风险增加有关。比利时老年病学和老年医学学会制定了肌肉减少症预防和治疗的循证指南。本综述汇总了营养干预工作组的结果。
本综述的目的是提供针对≥65 岁人群肌肉减少症或至少 1 项肌肉减少症标准(即肌肉质量、肌肉力量或身体机能)的营养干预措施的循证概述。
根据系统评价和荟萃分析的首选报告项目,检索了 PubMed 和 Web of Science 数据库中报告营养补充对肌肉减少症或肌肉质量、力量或身体机能影响的系统评价和荟萃分析。
两名作者提取了综述的关键特征数据,包括参与者、治疗和结局。使用评估系统评价的工具对综述的方法学质量进行了评估。三名作者根据对每项干预措施效果的综合分析,综合了提取的数据并提出了建议。证据质量使用推荐评估、制定和评估方法进行评级。
共纳入 15 项系统评价。检查了以下补充剂:蛋白质、必需氨基酸、亮氨酸、β-羟基-β-甲基丁酸、肌酸和多种营养素补充剂(有或没有体育锻炼)。由于综述数量少且质量低至中等,支持大多数建议的证据水平低至中等。
有最佳证据推荐亮氨酸,因为它对患有肌肉减少症的老年人的肌肉质量有显著影响。建议在抗阻训练的基础上补充蛋白质,以增加肌肉质量和力量,特别是对于肥胖者和持续≥24 周的患者。纳入的综述未报告关于肌肉减少症作为一个结构的效果。